Showing 1 - 10 of 33
We analyse the effect of competition on quality in hospital markets with regulated prices, considering both the effect of (i) introducing competition (monopoly versus competition) and (ii) increasing competition through lower transportation costs (increased substitutability) or a higher number...
Persistent link: https://www.econbiz.de/10013152862
This paper studies the effects of price regulation and parallel imports in the on-patent pharmaceutical market. In a … that the effects of stricter price regulation crucially depend on whether the producer faces competition from parallel … imports. While parallel imports improve the bargaining position of the distributor, price regulation counteracts this effect …
Persistent link: https://www.econbiz.de/10013017702
. Allowing for price cap regulation, we show that the negative effect on generic entry can be reversed, and that reference …
Persistent link: https://www.econbiz.de/10013024341
We investigate the effect of competition on quality in regulated markets (e.g., health care, higher education, public utilities), using a Hotelling framework, in the presence of sluggish demand. We take a differential-game approach, and derive the open-loop solution (providers choose the optimal...
Persistent link: https://www.econbiz.de/10013148292
This paper studies the effects of price regulation and parallel imports in the on-patent pharmaceutical market. First … prices. We show that the effects of price regulation crucially depend on whether the producer faces competition from parallel … imports. While parallel imports improve the bargaining position of the pharmacy, price regulation counteracts this effect and …
Persistent link: https://www.econbiz.de/10013060442
-patent pharmaceuticals, replacing the existing price cap (PC) regulation. We estimate the effect of the reform using a product level panel … dataset, covering the drugs exposed to RP and a large number of drugs still under PC regulation in the time before and after … regulation in lowering drug prices, while the cross-price effect raises a concern about patent protection …
Persistent link: https://www.econbiz.de/10013316907
We consider a therapeutic market with potentially three pharmaceutical firms. Two of the firms offer horizontally differentiated brand-name drugs. One of the brand-name drugs is a new treatment under patent protection that will be introduced if the profits are sufficient to cover the entry...
Persistent link: https://www.econbiz.de/10013317373
This paper studies the diffusion of biopharmaceuticals across European countries, focusing on anti-TNF drugs, which are used to treat autoimmune diseases (e.g., rheumatism, psoriasis). We use detailed sales information on the three brands Remicade, Enbrel and Humira for nine European countries...
Persistent link: https://www.econbiz.de/10014158749
We study the impact of product margins on pharmacies' incentive to promote generics instead of brand-names. First, we construct a theoretical model where pharmacies can persuade patients with a brand-name prescription to purchase a generic version instead. We show that pharmacies' substitution...
Persistent link: https://www.econbiz.de/10013139185
We study the incentives for hospitals to provide quality and expend cost-reducing effort when their budgets are soft, i.e., the payer may cover deficits or confiscate surpluses. The basic set up is a Hotelling model with two hospitals that differ in location and face demand uncertainty, where...
Persistent link: https://www.econbiz.de/10013108158